Feature Channels: OBGYN

Filters close
Newswise: Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Released: 29-Nov-2022 5:25 PM EST
Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant
Johns Hopkins Medicine

Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.

Newswise: Goal: Speeding Up Treatment for Pregnancy-Related Hypertension
Released: 29-Nov-2022 1:05 PM EST
Goal: Speeding Up Treatment for Pregnancy-Related Hypertension
Cedars-Sinai

An initiative developed by Cedars-Sinai investigators improves the timeliness of treatment for women with severe pregnancy-related hypertension, one of the leading causes of pregnancy-related death.

Released: 29-Nov-2022 12:05 PM EST
Pregnant women’s cannabis usage in legalized US states raises calls for screening
Taylor & Francis

Pregnant women living in US states where cannabis is legal must be screened for the drug, for the health of both mother and baby, claim scientists who in a new national study have found that they are far more likely to use the substance.

Released: 29-Nov-2022 12:00 PM EST
بحث مبكر حول إيجاد حل خالٍ من الخلايا لسلس البول الإجهادي
Mayo Clinic

أشارت الأبحاث قبل السريرية إلى أن العضلات الهيكلية المُجددة وأعراض سلس البول الإجهادي تحسنت بعد استخدام مادة خالية من الخلايا اكتُشفت في مايو كلينك. أشرف فريق عطا بحفر، دكتور الطب، الحاصل على الدكتوراه، وفريق إيمانويل ترابوكو، دكتو الطب، على هذا البحث بالتعاون مع قسم طب القلب والأوعية الدموية وقسم التوليد وأمراض النساء في مايو كلينك. الورقة البحثية منشورة في مجلة إن بي جيه للطب التجديدي.

Released: 29-Nov-2022 11:55 AM EST
Machine learning model builds on imaging methods to better detect ovarian lesions
Washington University in St. Louis

Research from Quing Zhu’s lab yields a novel method to use ultrasound to enhance machine learning's ability to accurately diagnose - or rule out - ovarian cancer.

Released: 28-Nov-2022 12:05 PM EST
Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy
Infectious Diseases Data Observatory (IDDO)

A new WWARN meta-analysis commissioned by the World Health Organization (WHO) which informed a change to its treatment guidelines* has been published in The Lancet.

Released: 28-Nov-2022 8:45 AM EST
Arthrex, Richard Wolf Announce Partnership to Expand Comprehensive Operative Care Solutions
Arthrex, Inc.

Arthrex and Richard Wolf, global leaders in minimally invasive surgical technology and solutions, announced a U.S.-based partnership to offer comprehensive technology and product offerings in urology, gynecology and general surgery.

   
Released: 22-Nov-2022 8:00 PM EST
Type 2 diabetes genes linked with gestational diabetes in South Asian women
eLife

The same complex genetics that contribute to a higher risk of type 2 diabetes may also increase the risk of developing diabetes during pregnancy among women of South Asian descent, a study published today in eLife shows.

Newswise: Risk of severe COVID-19 symptoms remains throughout pregnancy, study finds
Released: 22-Nov-2022 2:05 PM EST
Risk of severe COVID-19 symptoms remains throughout pregnancy, study finds
UT Southwestern Medical Center

A UT Southwestern study of more than 1,300 pregnant women diagnosed with COVID-19 found that just 1 in 10 developed moderate, severe, or critical illness and that COVID-19 symptoms and severity were similar across all trimesters.

Newswise: Brain Organoids Reveal in Detail the Harms of Prenatal Alcohol Exposure
Released: 18-Nov-2022 11:05 AM EST
Brain Organoids Reveal in Detail the Harms of Prenatal Alcohol Exposure
University of California San Diego

UC San Diego researchers used human brain organoids to study the effects of prenatal alcohol exposure on neural development, revealing significant harms in molecular detail.

Released: 17-Nov-2022 1:40 PM EST
UCI-led study finds virtual green space exposure beneficial to pregnant women
University of California, Irvine

Irvine, Calif., Nov. 17, 2022 – Pregnant women exposed to a green space environment in a virtual reality setting experienced decreases in blood pressure and improvements in mental health and well-being, according to a study led by the University of California, Irvine.  In a paper recently published in Environmental Research, co-corresponding author Jun Wu, Ph.

Newswise:Video Embedded pregnant-trauma-patients-with-certain-injury-patterns-should-be-screened-for-intimate-partner-violence-during-their-hospital-stay
VIDEO
Released: 17-Nov-2022 11:00 AM EST
Pregnant trauma patients with certain injury patterns should be screened for intimate partner violence during their hospital stay
American College of Surgeons (ACS)

Pregnant trauma patients with certain injury patterns—including multiple injuries, injuries to the head, face, neck, and scalp, and multiple contusions—should be screened for intimate partner violence (IPV), according to study results published in the Journal of the American College of Surgeons (JACS).

Newswise: A chip to replace animal testing
Released: 17-Nov-2022 6:05 AM EST
A chip to replace animal testing
Empa, Swiss Federal Laboratories for Materials Science and Technology

Empa researchers are developing a medical chip in collaboration with the ETH Zurich and the Cantonal Hospital of St.Gallen that will allow statements to be made about the effect of substances on babies in the womb. The Zurich-based ProCare Foundation is funding the project, which was recently launched.

   
Newswise: Threats of Covid-19 Caused Significant Anxiety and Depression in Pregnant Women
Released: 16-Nov-2022 8:05 AM EST
Threats of Covid-19 Caused Significant Anxiety and Depression in Pregnant Women
Stony Brook University

A published study that assessed anxiety and depressive symptoms in pregnant women from seven Western countries during the first major wave of the Covid-19 pandemic shows that stress from fears about Covid-19 led to anxiety and depressive symptoms above normal levels.

Released: 15-Nov-2022 9:05 PM EST
Study: COVID-19 policies harmed minority women's perinatal experiences, magnified inequities
University of Illinois Urbana-Champaign

Black, Indigenous and other women of color who were pregnant or gave birth during the pandemic said these experiences were overshadowed by isolation, confusion and fear, much of it caused by unclear or frequently changing institutional policies, according to a new study.

Released: 15-Nov-2022 1:40 PM EST
Limited postpartum follow-up may miss high blood pressure in 1 in 10 new moms
American Heart Association (AHA)

An analysis of more than 2,400 women who did not have high blood pressure while pregnant found that about 1 in 10 were diagnosed with high blood pressure in the year after childbirth.

Released: 15-Nov-2022 11:05 AM EST
How hormonal birth control may affect the adolescent brain
Ohio State University

Reproductive health experts consider hormonal contraceptives good choices for adolescents because they’re safe and highly effective at preventing pregnancy, but one aspect of their effect on the teenage body remains a mystery – whether and how they modify the developing brain.

Newswise: Podcast: Epilepsy medications during pregnancy may affect infant development
Released: 15-Nov-2022 8:05 AM EST
Podcast: Epilepsy medications during pregnancy may affect infant development
International League Against Epilepsy

A recent study reported data from more than 1,300 infants whose mothers are enrolled in the Kerala Registry of Epilepsy in Pregnancy. Babies were evaluated for mental and motor development at 1 year of age.

Newswise: Mount Sinai Appoints Michal A. Elovitz, MD, as Dean for Women’s Health
Released: 15-Nov-2022 6:00 AM EST
Mount Sinai Appoints Michal A. Elovitz, MD, as Dean for Women’s Health
Mount Sinai Health System

Renowned preterm birth expert to lead efforts to improve women’s health and educate and empower women researchers

Released: 15-Nov-2022 12:05 AM EST
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
RareCyte, Inc.

RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services has been selected by Wellcome Leap to participate in the $50M In Utero program to create the scalable capacity to measure, model and predict gestational development, to achieve the goal of reducing global stillbirth rates by half.

   
Newswise: Hormone therapy has value to relieve menopause symptoms
Released: 14-Nov-2022 7:55 PM EST
Hormone therapy has value to relieve menopause symptoms
University of Washington School of Medicine

For the last 20 years, however, Dr. Susan Reed and other clinicians who treat menopausal symptoms have had to fence with recommendations from the U.S. Preventive Services Task Force (USPSTF), a body that provides guidance for medication use with such chronic disease conditions as osteoporosis, heart disease, dementia and diabetes.

Released: 11-Nov-2022 3:05 PM EST
Decades-Long Push to Lower Stillbirth Rate in the U.S. Has Stalled
Rutgers University-New Brunswick

A decades-long effort to lower the stillbirth rate in the United States has stalled, as has progress in closing a persistent gap in excess stillbirths experienced by Black women compared with White women, according to a Rutgers-led study.

Released: 11-Nov-2022 9:55 AM EST
Penn Medicine Receives $3.5 Million NCI Grant to Improve Cervical Cancer Care in Botswana
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine experts have worked with local partners to improve health care in Botswana for years. Now, a new $3.5 million grant from the NCI will help further that work by addressing one of Botswana’s most serious health challenges: cervical cancer.

Released: 10-Nov-2022 1:20 PM EST
Penn Study Illuminates Why Cancers Caused by BRCA Mutations Recur
Perelman School of Medicine at the University of Pennsylvania

Researchers at the University of Pennsylvania’s Basser Center for BRCA at the Abramson Cancer Center have discovered factors that may make breast and ovarian cancers associated with BRCA1/2 gene mutations more likely to recur.

Released: 10-Nov-2022 11:55 AM EST
Dimension Inx and Lurie Children’s Hospital of Chicago awarded joint NIH grant to expand fertility restoration options
Ann and Robert H. Lurie Children's Hospital of Chicago

Dimension Inx, a regenerative biomaterials company, and Ann & Robert H. Lurie Children’s Hospital of Chicago have been jointly awarded an NIH Exploratory/Developmental Research Grant.

Newswise: Study: Biomarkers That Predict Preeclampsia Risk
Released: 9-Nov-2022 3:35 PM EST
Study: Biomarkers That Predict Preeclampsia Risk
Cedars-Sinai

In a study of pregnant women in the United States, Cedars-Sinai investigators found that a specific imbalance of two placental proteins could predict which women were at risk of developing a severe form of preeclampsia, a life-threatening blood pressure disorder.

Released: 9-Nov-2022 3:15 PM EST
Knowledge is power. The latest research on arthritis is right at your fingertips
Newswise

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

Released: 8-Nov-2022 3:20 PM EST
Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients
Cleveland Clinic

Antibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer progression and lower survival rates, according to recent Cleveland Clinic research.

2-Nov-2022 10:15 AM EDT
Managing Eczema in Babies: Five Things to Know
McMaster University

Five key messages for general and specialist care providers, as well as caregivers, promote best practices for managing atopic dermatitis in infants.

Newswise: RUDN Researchers Propose a Non-Invasive Method for the Treatment of Endometriosis
Released: 6-Nov-2022 12:05 PM EST
RUDN Researchers Propose a Non-Invasive Method for the Treatment of Endometriosis
Scientific Project Lomonosov

RUDN scientists have shown the possibility of treating endometriosis with the help of macrophages - immune cells that help fight foreign agents. A new approach in the future can replace the standard treatment with surgery.

Released: 6-Nov-2022 9:15 AM EST
Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery
Duke Health

For more than four decades, doctors have been split on whether giving steroids during a pediatric open-heart surgery could be helpful for post-operative recovery. A new study is providing a bit more clarity, suggesting there are some benefits for certain kinds of patients.

Released: 4-Nov-2022 12:10 PM EDT
Food Supplement Use During Pregnancy Differs From Recommendations
University of Turku (Turun yliopisto)

Although a majority of pregnant women believed that they were aware of the recommendations on food supplement use, the recommendations were not always adhered to in practice, shows a study conducted at the University of Turku, Finland.

Released: 3-Nov-2022 8:05 AM EDT
Time to Extubate Varies Widely After Mandibular Distraction Osteogenesis
Children's Hospital Los Angeles

Nearly two decades ago, Children’s Hospital Los Angeles was among a handful of centers that pioneered mandibular distraction osteogenesis (MDO) for infants with airway obstructions due to micrognathia (undersized jaw).

Newswise: Researchers Find No Decrease in Preterm Births with Vaginal Progesterone
Released: 1-Nov-2022 4:30 PM EDT
Researchers Find No Decrease in Preterm Births with Vaginal Progesterone
UT Southwestern Medical Center

Vaginal progesterone, a hormone treatment considered the standard of care for preventing preterm birth in at-risk pregnant women, may not be effective, according to UT Southwestern Medical Center researchers.

Released: 1-Nov-2022 2:20 PM EDT
Youngest Girls Who Get Pregnant Have Highest Risk of Poor Outcomes, Study Finds
University of Maryland School of Medicine

Pregnant teens in the U.S. have long been known to face increased health risks and pregnancy complications, but a new study for the first time finds that girls ages 13 or younger who get pregnant face even greater risks. These very young girls are significantly more likely to experience preterm birth, cesarean delivery, and admission to the intensive care unit (ICU) compared to older pregnant teens.

Newswise:Video Embedded boo-tiful-babies-continue-25-year-halloween-tradition-at-cedars-sinai
VIDEO
Released: 28-Oct-2022 10:05 PM EDT
“Boo”-tiful Babies Continue 25-Year Halloween Tradition at Cedars-Sinai
Cedars-Sinai

Once again this year, the Neonatal Intensive Care Unit (NICU) at Cedars-Sinai Guerin Children’s celebrated Halloween with special hand-sewn costumes for the medical center’s smallest babies. The costumes are designed for babies as little as 2 pounds and are based on characters in famous children’s books.

Released: 28-Oct-2022 11:50 AM EDT
When Tapas Can Cause Harm: Large Listeriosis Outbreak in Spain
European Centre for Disease Prevention and Control (ECDC)

Listeria bacteria are ubiquitous in the environment and consumption of food contaminated with Listeria monocytogenes is one of the main routes for food-borne outbreaks.

27-Oct-2022 10:25 AM EDT
Study Finds Persistent Disparities in Access to Prenatal Care Among Pregnant People Based on Citizenship Status and Education Level
Mount Sinai Health System

Findings suggest exclusions to Medicaid because of immigration status may increase risk for maternal health care disparities in some immigrant populations

Newswise: Yale Cancer Center Researchers Discover Differences in Response for Endometrial Cancer Treated with Pembrolizumab
Released: 27-Oct-2022 10:45 AM EDT
Yale Cancer Center Researchers Discover Differences in Response for Endometrial Cancer Treated with Pembrolizumab
Yale Cancer Center/Smilow Cancer Hospital

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade.

Newswise:Video Embedded new-lassa-fever-therapy-may-be-on-the-horizon
VIDEO
24-Oct-2022 3:20 PM EDT
New Lassa Fever Therapy May Be on the Horizon
La Jolla Institute for Immunology

The LJI team plans to use their new map of the Lassa virus surface glycoprotein to design a much-needed vaccine.

   
Newswise: Initiation of Intercourse Alters Vaginal Immune Environment
Released: 26-Oct-2022 1:55 PM EDT
Initiation of Intercourse Alters Vaginal Immune Environment
University of Washington School of Medicine

UW Medicine researchers compared vaginal samples collected from 95 young women or adolescent study participants in Kenya before or after they began having sexual intercourse. They found a sharp increase in proteins that control the immune response, including IL-1β, IL-2, and CXCL8, during the first year after becoming sexually active.

Released: 26-Oct-2022 12:50 PM EDT
Autistic People Are More Likely to Experience Depression and Anxiety During Pregnancy
University of Cambridge

Autistic people are more vulnerable to depression and anxiety during pregnancy, according to new research from the University of Cambridge.

Released: 25-Oct-2022 2:50 PM EDT
妙佑医疗国际(Mayo Clinic)问与答:专家介绍如何使用Botox治疗偏头痛
Mayo Clinic

尊敬的妙佑医疗国际:我的偏头痛断断续续发作已有五年了,为此我饱受折磨。最近,我发现自己平时服用的口服药物似乎也没那么有效了。我知道市面上有一些更新型的药物,但一位朋友建议我试一试Botox注射。她很认真地告诉我,正是这种药物使她的慢性头痛得到了控制。我想请问一下,Botox注射的安全性怎么样?是如何起作用的?这种药物的治疗方案是什么?需要结合使用其他头痛药物吗?答:Botox又名A型肉毒杆菌毒素,其于2010年经美国食品药品管理局批准用于治疗慢性偏头痛。这种药物并不能根治此病。使用Botox注射治疗头痛的患者通常需要每三个月接受一次注射。

Released: 25-Oct-2022 2:45 PM EDT
أسئلة وأجوبة مايو كلينك: خبير يشرح كيفية استخدام البوتوكس في علاج الصداع النصفي
Mayo Clinic

عزيزتي مايو كلينك: أعاني من الشقيقة (الصداع النصفي) بشكل متقطع لمدة خمس سنوات تقريبًا. في الآونة الأخيرة، يبدو أن العلاج الفموي الذي أستخدمه أقل فعالية. بالرغم من أنني أعلم بوجود أدوية جديدة، فقد اقترحت عليَّ إحدى صديقاتي أن أجرب حُقن البوتوكس. حيث تُقسم أنه سيطر على الصداع المزمن لديها. ما مدى أمان هذه الحقن وكيف يعمل البوتوكس؟ ما هو جدول العلاج، وهل سأحتاج أيضًا إلى تناول أدوية أخرى للصداع؟ الإجابة: تمت الموافقة على توكسين أونابوتولينوم أ، أو البوتوكس، من قبل إدارة الغذاء والدواء الأمريكية في عام 2010 لعلاج الشقيقة (الصداع النصفي) المزمنة. ولكنه ليسَ علاجًا نهائيًا. عادةً ما يتلقى الأشخاص الذين يتلقون حقن البوتوكس للصداع العلاج كل ثلاثة أشهر تقريبًا.

Released: 25-Oct-2022 2:45 PM EDT
Perguntas E Respostas Da Mayo Clinic: Especialista Explica Como O Botox é Usado Para Tratar as Enxaquecas
Mayo Clinic

ESTIMADA MAYO CLINIC: venho sofrendo com enxaquecas intermitentes há mais ou menos cinco anos. Recentemente, a terapia oral que venho usando parece não estar mais fazendo efeito. Apesar de saber que novos medicamentos estão disponíveis, uma amiga sugeriu que eu experimentasse injeções de Botox. Ela jura que as injeções deixaram seus níveis de dores de cabeça sob controle. Essas injeções são seguras e como o Botox funciona? Qual é o cronograma de tratamento e eu também precisaria tomar outros medicamentos para dor de cabeça? RESPOSTA: a toxina Onabotulínica A, ou Botox, foi aprovada pela Food and Drug Administration (Administração de Alimentos e Medicamentos dos Estados Unidos) em 2010 para tratar enxaquecas. Não se trata de uma cura. As pessoas que recebem injeções de Botox para dores de cabeça geralmente recebem o tratamento mais ou menos a cada três meses.

Released: 25-Oct-2022 2:40 PM EDT
Preguntas Y Respuestas De Mayo Clinic: Un Experto Explica De Qué Manera Se Utiliza El BóTox Para Tratar La Migraña
Mayo Clinic

ESTIMADA MAYO CLINIC: He sufrido migraña de forma intermitente durante aproximadamente cinco años. En el último tiempo, la terapia oral que he recibido pareciera ser menos eficaz. Si bien sé que existen medicamentos más nuevos, una amiga me sugirió que pruebe las inyecciones de bótox. Mi amiga jura que el bótox controló sus dolores de cabeza crónicos. ¿Cuán seguras son estas inyecciones? ¿Cómo funciona el bótox? ¿Cuál es el plan de tratamiento? ¿También tendría que tomar otro medicamento para el dolor de cabeza? RESPUESTA: La onabotulinumtoxina A, o el bótox, fue aprobada por la Administración de Alimentos y Medicamentos en el 2010 para el tratamiento de los dolores de cabeza por migraña crónicos. No es una cura. Las personas que reciben inyecciones de bótox para los dolores de cabeza suelen recibir el tratamiento aproximadamente cada tres meses.



close
1.93361